IAMA, PsychoGenics, Sign Second Therapy Development Agreement
IAMA Therapeutics has signed a second agreement with PsychoGenics to test the effectiveness of new therapy candidates in Dravet syndrome animal models. The companies entered into a service agreement last year to identify the effectiveness of new drug candidates…